ECONOMIC EVALUATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY FOR PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW. Proceedings of the Global Public Health Conference, [S. l.], v. 9, n. 01, p. 14–30, 2026. DOI: 10.17501/26138417.2026.9102. Disponível em: https://proceedings.tiikmpublishing.com/index.php/globheal/article/view/1885. Acesso em: 4 aug. 2026.